Gabelli Funds LLC Bristol Myers Squibb CO Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gabelli Funds LLC holds 334,800 shares of BMY stock, worth $19.7 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

334,800

Previous 366,450 8.64%

Holding current value

$19.7 Million

Previous $15.2 Million 13.85%

% of portfolio

0.14%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $1.26 Million - $1.64 Million	-31,650 Reduced 8.64%	334,800 $17.3 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $1.19 Million - $1.57 Million	-29,600 Reduced 7.47%	366,450 $15.2 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $3.25 Million - $3.68 Million	-67,645 Reduced 14.59%	396,050 $21.5 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $58,903 - $70,287	-1,215 Reduced 0.26%	463,695 $23.8 Million
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $1.11 Million - $1.24 Million	-19,150 Reduced 3.96%	464,910 $27 Million
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $416,663 - $462,639	-6,540 Reduced 1.33%	484,060 $31 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $188,916 - $214,273	2,875 Added 0.59%	490,600 $34 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $202,016 - $239,215	-2,950 Reduced 0.6%	487,725 $35.1 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $2,628 - $1.55 Million	-20,223 Reduced 3.96%	490,675 $34.9 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $954,226 - $1.05 Million	-13,140 Reduced 2.51%	510,898 $39.3 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $1.45 Million - $1.74 Million	-23,550 Reduced 4.3%	524,038 $38.3 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $3.74 Million - $4.36 Million	-69,658 Reduced 11.29%	547,588 $34.1 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $1.77 Million - $2.07 Million	-29,916 Reduced 4.62%	617,246 $36.5 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $209,255 - $227,879	-3,380 Reduced 0.52%	647,162 $43.2 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $1.85 Million - $2.09 Million	31,242 Added 5.04%	650,542 $41.1 Million
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $4.44 Million - $5.03 Million	-76,950 Reduced 11.05%	619,300 $38.4 Million
Q3 2020 Nov 06, 2020	SELL	$57.43 - $63.64 $2.35 Million - $2.61 Million	-41,000 Reduced 5.56%	696,250 $42 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $23.3 Million - $27.3 Million	-425,310 Reduced 36.58%	737,250 $43.4 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $2.64 Million - $3.83 Million	-56,840 Reduced 4.66%	1,162,560 $64.8 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $28 Million - $36.5 Million	569,400 Added 87.6%	1,219,400 $78.3 Million
Q3 2019 Nov 01, 2019	SELL	$42.77 - $50.71 $1.15 Million - $1.37 Million	-26,987 Reduced 3.99%	650,000 $33 Million
Q2 2019 Aug 02, 2019	SELL	$44.62 - $49.34 $557,750 - $616,750	-12,500 Reduced 1.81%	676,987 $30.7 Million
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $1.46 Million - $1.74 Million	-32,300 Reduced 4.48%	689,487 $32.9 Million
Q4 2018 Jan 30, 2019	SELL	$48.76 - $63.23 $146,280 - $189,690	-3,000 Reduced 0.41%	721,787 $37.5 Million
Q3 2018 Nov 02, 2018	BUY	$55.19 - $62.25 $38,633 - $43,575	700 Added 0.1%	724,787 $45 Million
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $1.26 Million - $1.57 Million	-25,000 Reduced 3.34%	724,087 $40.1 Million
Q1 2018 May 09, 2018	BUY	$59.92 - $68.98 $1.66 Million - $1.91 Million	27,700 Added 3.84%	749,087 $47.4 Million
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $6.35 Million - $6.93 Million	-106,000 Reduced 12.81%	721,387 $44.2 Million
Q3 2017 Nov 01, 2017	BUY	$55.23 - $63.74 $45.7 Million - $52.7 Million	827,387	827,387 $52.7 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Bristol Myers Squibb CO Transaction History